Detalhe da pesquisa
1.
Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification.
Br J Haematol
; 204(4): 1529-1535, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38411250
2.
Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry.
Haematologica
; 109(1): 115-128, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37199127
3.
Validation of mutated CEBPA bZIP as a distinct prognosis entity in acute myeloid leukemia: a study by the Spanish PETHEMA registry.
Haematologica
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38634126
4.
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia.
Blood
; 137(14): 1879-1894, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33150388
5.
Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials.
Haematologica
; 108(4): 969-980, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36325893
6.
Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia.
Haematologica
; 108(8): 2059-2066, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36815361
7.
Prognostic heterogeneity of adult B-cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3-PBX1 treated with measurable residual disease-oriented protocols.
Br J Haematol
; 196(3): 670-675, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34549416
8.
5'-nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate-risk cytogenetics.
Eur J Haematol
; 109(6): 755-764, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36063368
9.
Multi-body-site colonization screening cultures for predicting multi-drug resistant Gram-negative and Gram-positive bacteremia in hematological patients.
BMC Infect Dis
; 22(1): 172, 2022 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35189833
10.
A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia.
Cancer
; 127(12): 2003-2014, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33626197
11.
Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations.
Br J Haematol
; 194(4): 708-717, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34296432
12.
Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project
Haematologica
; 106(12): 3079-3089, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33179471
13.
Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials.
Hematol Oncol
; 39(4): 529-538, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34405901
14.
Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease.
Br J Haematol
; 191(1): 52-61, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32510599
15.
Impact of clinical features, cytogenetics, genetic mutations, and methylation dynamics of CDKN2B and DLC-1 promoters on treatment response to azacitidine.
Ann Hematol
; 99(3): 527-537, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31989250
16.
Characteristics and outcome of adult patients with acute promyelocytic leukemia and increased body mass index treated with the PETHEMA Protocols.
Eur J Haematol
; 104(3): 162-169, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31724208
17.
Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols.
Eur J Haematol
; 105(2): 138-147, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32243655
18.
Early adjustment of empirical antibiotic therapy of bloodstream infections on the basis of direct identification of bacteria by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and Gram staining results.
J Infect Chemother
; 26(9): 963-969, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32386929
19.
Molecular profiling refines minimal residual disease-based prognostic assessment in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.
Genes Chromosomes Cancer
; 58(11): 815-819, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31340073
20.
Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA Group.
Cancer
; 125(16): 2810-2817, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31012967